Table 1.
Patient Characteristics
| Patient Characteristics | Arm A (n = 43) | Arm B (n = 47) | p Value |
|---|---|---|---|
| Median age (range) | 69 y (62–75) | 67 y (60–72) | 0.23 |
| Gender, n (%) | |||
| Female | 19 (44) | 23 (49) | 0.65 |
| Male | 24 (56) | 24 (51) | |
| ECOG performance status, n (%) | |||
| 0 | 14 (33) | 13 (28) | 0.62 |
| 1 | 29 (67) | 34 (72) | |
| History of tobacco use, n (%) | |||
| Current | 9 (21) | 14 (30) | 0.57 |
| Previous | 31 (72) | 29 (62) | |
| Never | 3 (7) | 4 (8) | |
| Histology, n (%) | |||
| Nonsquamous | 34 (79) | 37 (79) | 0.97 |
| Squamous | 9 (21) | 10 (21) | |
| EGFR or ALK status,a n (%) | |||
| EGFR mutation positive | 1 (2) | 0 | |
| ALK rearrangement | 0 | 0 |
ECOG, Eastern Cooperative Oncology Group.
a
EGFR and ALK testing performed per standard of care before trial enrollment. Data available on EGFR testing for 71 patients and on ALK testing for 63 patients.